(17280550), M. A., (14153247), A. Q. K., (17346850), R. A., (134672), F. A., (17346853), J. M. M., (5775911), S. S. R., . . . (154400), S. U. (2022). Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways.
Chicago Style (17th ed.) Citation(17280550), Maha Al-Tamimi, et al. Pristimerin Mediated Anticancer Effects and Sensitization of Human Skin Cancer Cells Through Modulation of MAPK Signaling Pathways. 2022.
MLA (9th ed.) Citation(17280550), Maha Al-Tamimi, et al. Pristimerin Mediated Anticancer Effects and Sensitization of Human Skin Cancer Cells Through Modulation of MAPK Signaling Pathways. 2022.
Warning: These citations may not always be 100% accurate.